- Lobbying
- Charles AND Pritchard
Lobbying Arrangements Results for 'Charles Pritchard'
Former Covered Federal Workers:
Other Lobbyists:
Issue | Client | Firm | Lobbyists | Start Date | Latest Filing Date |
---|---|---|---|---|---|
Details Issues related to telehealth/telemedicine, prescribing, and pharmacy dispensing of medications. Issues related to telehealth/telemedicine and pharmacies. |
Circle Medical
|
Faegre Drinker Biddle & Reath LLP | |||
Details Issues related to solar energy generally, rooftop solar specifically; Solar / PV recycling issues; Add H.R. 5997 / S. 3099, the SHINE Act. |
Renova Energy (Formerly Renova Solar)
|
Faegre Drinker Biddle & Reath LLP | |||
Details Issues related to compounding medications, including safety and supply chain issues. |
Empower Pharmacy
|
Faegre Drinker Biddle & Reath LLP | |||
Details NIH, CDC, FDA, and DOD issues and funding relating to muscular dystrophy research and programs. |
Parent Project Muscular Dystrophy
|
Faegre Drinker Biddle & Reath LLP | |||
Details FY 24 appropriations issues pertaining to Inflammatory Bowel Diseases. Step therapy and utilization management protocols including the Safe Step Act (S. 652 and H.R. 2360); pharmacy benefit manager... |
Crohn's & Colitis Foundation
|
Faegre Drinker Biddle & Reath LLP | |||
Details Issues around food as medicine interventions in the Medicare program. |
Step One Foods
|
Faegre Drinker Biddle & Reath LLP | |||
Details S. 2226 / H.R. 2670, the National Defense Authorization Act (including the bill numbers to update the generic NDAA. Issues related to the AbilityOne program. Issues related to the AbilityOne progr... |
IFB Solutions
|
Faegre Drinker Biddle & Reath LLP | |||
Details Issues related to extension of the National Flood Insurance Program; enactment of a safe harbor for insurers of state-legal cannabis businesses; Establishment of the National Association of Registe... |
Wholesale & Specialty Insurance Association
|
Faegre Drinker Biddle & Reath LLP | |||
Details Antibiotic Use in Livestock ---H.R.4012: To repeal the guidance titled "CVM GFI #263 Recommendations for Sponsors of Medically Important Antimicrobial Drugs Approved for Use in Animals to Voluntar... |
Biotechnology Innovation Organization
|
in-house lobbying |